COPD - Nationale VersorgungsLeitlinien

239. Emerman CL,Cydulka RK. Use of peak expiratory flow rate in emergency department evaluation of
acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1996;27(2):159-63.
240. Emerman CL, Lukens TW, Effron D. Physician estimation of FEV1 in acute exacerbation of COPD.
Chest 1994;105(6):1709-12.
241. Emerman CL, Effron D, Lukens TW. Spirometric criteria for hospital admission of patients with acute
exacerbation of COPD. Chest 1991;99(3):595-9.
242. Meissner E, Niedermeyer J, Worth H, Dorow P, Thalhofer S, Petermann W, Breuer HW, Borst MM,
Olschewski H, Rasche K, Oertel R, Sill V. Diagnostik der akuten Lungenembolie. Empfehlungen der
Deutschen Gesellschaft für Pneumologie. Pneumologie 2000;54(12):587-91.
243. Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital
stay for chronic pulmonary disease. JAMA 1991;266(1):80-3.
244. Gibson PG, Wlodarczyk JH, Wilson AJ, Sprogis A. Severe exacerbation of chronic obstructive
airways disease: health resource use in general practice and hospital. J Qual Clin Pract
1998;18(2):125-33.
245. Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF, Jr., Phillips RS. A comparison of
generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary
disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to
Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Am J Med
1998;105(5):366-72.
246. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and
outcome of adult lower-respiratory-tract infections in the community. Lancet 1993;341(8844):511-4.
247. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of
patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary
disease. JAMA 1995;274(23):1852-7.
248. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G. Predicting
mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am
J Med 1995;98(3):272-7.
249. Kong GK, Belman MJ, Weingarten S. Reducing length of stay for patients hospitalized with
exacerbation of COPD by using a practice guideline. Chest 1997;111(1):89-94.
250. Connors AF, Jr., Dawson NV, Thomas C, Harrell FE, Jr., Desbiens N, Fulkerson WJ, Kussin P,
Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic
obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and
Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154(4 Pt
1):959-67.
251. Emerman CL, Connors AF, Lukens TW, May ME, Effron D. Theophylline concentrations in patients
with acute exacerbation of COPD. Am J Emerg Med 1990;8(4):289-92.
252. Lloberes P, Ramis L, Montserrat JM, Serra J, Campistol J, Picado C, Agusti-Vidal A. Effect of three
different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. Eur
Respir J 1988;1(6):536-9.
253. Mahon JL, Laupacis A, Hodder RV, McKim DA, Paterson NA, Wood TE, Donner A. Theophylline for
irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice.
Chest 1999;115(1):38-48.
254. Barbera JA, Reyes A, Roca J, Montserrat JM, Wagner PD, Rodriguez-Roisin R. Effect of
intravenously administered aminophylline on ventilation/perfusion inequality during recovery from
exacerbations of chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145(6):1328-33.
93
© 2006